Rabies virus as vector for development of vaccine: pros and cons.

The article explores the use of the rabies virus as a tool for developing vaccines. It discusses the different types of rabies virus-vectored vaccines and their strengths and weaknesses. Live-attenuated vaccines offer long-lasting protection but carry a risk of reversion to virulence, while inactivated vaccines have a good safety profile but may require booster injections. Further research is needed to fully understand and utilize the potential of these vaccines. The document also compiles various scientific studies that demonstrate the efficacy and safety of rabies virus-based vaccines for diseases such as HIV-1, Lassa fever, and SARS-CoV-2. The research suggests that rabies virus vectors have the potential to be effective vaccines for a wide range of infectious diseases. [Extracted from the article]